(Q74552676)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9588838%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

review article

1 reference

title

Induction of colitis in IL2-deficient-mice: the role of thymic and peripheral dysregulation in the generation of autoreactive T cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9588838%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9588838%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

R O Ehrhardt

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9588838%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 October 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9588838%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

published in

Research in Immunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9588838%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

148

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9588838%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

8-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9588838%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

582-588

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9588838%20AND%20SRC:MED&resulttype=core&format=json

Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Interleukin-10-deficient mice develop chronic enterocolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Chronic intestinal inflammation: an unexpected outcome in cytokine or T cell receptor mutant mice

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Reactivity of infiltrating T lymphocytes with microbial antigens in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Lack of induction of suppressor T cells by intestinal epithelial cells from patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

The role of IL-12 in the induction of organ-specific autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Cytokines in intestinal inflammation: pathophysiological and clinical considerations.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

The immunopathogenesis of gastrointestinal and hepatobiliary diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR)

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Decreased mucosal interleukin-4 (IL-4) production in gut inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Cytokine imbalance and autoantibody production in T cell receptor-alpha mutant mice with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin-2-deficient colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Gi2 alpha protein deficiency: a model of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Expression of pro-inflammatory cytokines by TCR alpha beta+ and TCR gamma delta+ T cells in an experimental model of colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Antibodies to interleukin 12 abrogate established experimental colitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

T-cell tolerance and autoimmunity in transgenic models of central and peripheral tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

The thymus and T-cell tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

1 reference

7 January 2021

Effect of interleukin 2 on fetal thymocytes in organ cultures: generation of lymphokine-activated killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Expression and function of interleukin-2 receptors on immature thymocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

lnterleukin-2-dependent autocrine proliferation in T-cell development

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Induction of interleukin 2 receptor beta chain expression by self-recognition in the thymus

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

CD3-mediated apoptosis of human medullary thymocytes and activated peripheral T cells: respective roles of interleukin-1, interleukin-2, interferon-gamma and accessory cells

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Immunopathology of interleukin (IL) 2-deficient mice: thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Severe colitis in mice with aberrant thymic selection

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Autoimmunity caused by disruption of central T cell tolerance. A murine model of drug-induced lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Immune activation genes in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

A controlled trial of anti-tumor necrosis factor alpha antibody for Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Monoclonal antibody therapy of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2898%2980153-3

7 January 2021

10.1016/S0923-2494(98)80153-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9588838%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference